Kestra Medical Technologies, Ltd. Net Income (Loss) Available to Common Stockholders, Diluted
Kestra Medical Technologies, Ltd. (KMTS) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$44.09 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-09-14
- Kestra Medical Technologies, Ltd. net income (loss) available to common stockholders, diluted for the quarter ending 2026-07-31 was -$44.09M.
- Kestra Medical Technologies, Ltd. net income (loss) available to common stockholders, diluted for the quarter ending 2026-04-30 was -$38.84M.
- Kestra Medical Technologies, Ltd. net income (loss) available to common stockholders, diluted for the quarter ending 2026-01-31 was -$34.17M.
- Kestra Medical Technologies, Ltd. net income (loss) available to common stockholders, diluted for the quarter ending 2025-10-31 was -$32.78M.
- Kestra Medical Technologies, Ltd. net income (loss) available to common stockholders, diluted for fiscal 2026 was -$131.61M.
- Kestra Medical Technologies, Ltd. net income (loss) available to common stockholders, diluted for fiscal 2025 was -$126.14M.
- Kestra Medical Technologies, Ltd. net income (loss) available to common stockholders, diluted for fiscal 2024 was -$100.84M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|
| 2026-07-31 | -$44.09M 10-Q · filed 2026-09-14 | -$82.92M derived: sum of 2 quarters · filed 2026-09-14 | -$117.09M derived: sum of 3 quarters · filed 2026-09-14 | -$149.87M derived: sum of 4 quarters · filed 2026-09-14 |
| 2026-04-30 | -$38.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | -$73.00M derived: sum of 2 quarters · filed 2026-07-14 | -$105.79M derived: sum of 3 quarters · filed 2026-07-14 | -$131.61M 10-K · filed 2026-07-14 |
| 2026-01-31 | -$34.17M 10-Q · filed 2026-03-17 | -$66.95M derived: sum of 2 quarters · filed 2026-03-17 | -$92.78M 10-Q · filed 2026-03-17 | -$148.12M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-10-31 | -$32.78M 10-Q · filed 2025-12-11 | -$58.61M 10-Q · filed 2025-12-11 | -$113.95M derived: sum of 3 quarters · filed 2026-09-14 | -$138.79M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-07-31 | -$25.83M 10-Q · filed 2026-09-14 | -$81.17M derived: sum of 2 quarters · filed 2026-09-14 | -$106.00M derived: sum of 3 quarters · filed 2026-09-14 | -$129.69M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-04-30 | -$55.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | -$80.18M derived: sum of 2 quarters · filed 2026-07-14 | -$103.87M derived: sum of 3 quarters · filed 2026-07-14 | -$126.14M 10-K · filed 2026-07-14 |
| 2025-01-31 | -$24.83M 10-Q · filed 2026-03-17 | -$48.52M derived: sum of 2 quarters · filed 2026-03-17 | -$70.79M 10-Q · filed 2026-03-17 | |
| 2024-10-31 | -$23.69M 10-Q · filed 2025-12-11 | -$45.96M 10-Q · filed 2025-12-11 | ||
| 2024-07-31 | -$22.27M 10-Q · filed 2025-09-12 | |||
| 2024-04-30 | -$100.84M 10-K · filed 2025-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |